Spotting the Mutants to find the missing millions infected with Hepatitis B virus

-
Say blood transmitted disease and the first name that comes to mind is HIV infection. But did you know that 9 times more people are infected with Hepatitis than HIV?

28th July every year is recognized as World Hepatitis Day, in an effort to create awareness to eradicate the deadly virus by 2030. The second major infectious disease after tuberculosis, Hepatitis affects 325 million people worldwide, claiming 4,000 lives a day! What is ironical is that 290 of these 325 million people are unaware of their infection!* That's the story of the missing millions..

Not just globally, hepatitis is a severe health challenge in India as well. According to a 2017 study published in the Journal of Clinical and Translational Hepatology, India has a disease burden of about 50 mn; second only to China; with a prevalence of 2-7%.**

Hepatitis B infection shows no symptoms

Of the five strains A,B,C,D and E of the Hepatitis virus, Hepatitis B virus (HBV) is 50-100 times more infectious than HIV. HBV infection occurs as acute or a chronic, with chronic HBV infection being the most common presentation of the disease. Without intervention, 15% to 40% of chronic HBV-infected individuals go on to develop cirrhosis, end-stage liver disease, hepatocellular carcinoma (HCC), or require liver transplantation.

HBV spreads through contact with infected serum, sexual activity, unsafe transfusions and vertical transmission from mother to infant. In endemic areas, most infections occur at birth or during early childhood. Probability of chronic HBV infection in neonates is far more than 90% and in children 2-5 years of age about 30%. But this disease, unlike most others, will remain dormant for several years, before it manifests and show ups as liver cirrhosis or cancer in 20-30% of those suffering from infection.

Why accurate diagnosis is essential?

The lack of symptoms only makes the situation worse. Accurate diagnosis is therefore essential for prevention of transmission and effective treatment. For serodiagnosis, HBsAg (Hepatitis B surface antigen) and HBeAg (Hepatitis B envelope antigen) are two HBV specific antigens that can be detected directly in the serum of an infected person.

HBsAg is the major viral immunogenic surface protein, produced in all strains of HBV. It can be detected in the serum as a diagnostic marker of active HBV replication. Its presence in the serum for more than 6 months, indicates a chronic HBV infection.

Diagnostic Assays for HBV

Antibody detection, namely detection of anti HBsAg and antiHBe is not useful in diagnosing chronic HBV infection. The presence of anti-HBs (antibody against HBsAg) indicates either a past HBV infection or recent vaccination. Anti-HBe (antibody against HBeAg) indicates lower levels of HBV and low contagiousness.


Mutations pose a challenge in diagnosis

The HBsAg has a single major antigenic determinant, called the ‘a determinant’. Mutations inducing a conformational change within the ‘a determinant’, may result in a variant epitope of HBsAg, that is not recognized by some diagnostic assays. A number of studies have evaluated the available HBsAg diagnostic assays for their ability to detect well-defined HBsAg mutants.

Currently, a majority of the diagnostic assays use monoclonal antibodies directed to the “a” determinant of HBsAg, in order to capture the protein. Mutations within this region, change the ability of the protein to be detected by monoclonal antibodies. Thus, monoclonal antibodies alone may not be sufficient to detect altered HBsAg associated with mutations. A more robust approach is to use a pool of well-characterized polyclonal antibodies directed to HBsAg. Polyclonal antibody based assays appear to detect mutant HBsAg as well.

Advanced test kits from Transasia

Transasia has developed advanced HBsAg ELISA kits, ErbaLisa PICO HBsAg and ErbaLisa SEN HBsAg, with a pool of polyclonal antibodies coated on the microwells to maximize the sensitivity for HBsAg mutants. The conjugate reagent contains monoclonal antibodies specific to HBsAg, thereby ensuring better specificity too.

ErbaLisa SEN HBsAg and ErbaLisa PICO HBsAg also offer best in class analytical sensitivity of 0.1 ng/ml and <50 pg/ml respectively with a turnaround time (TAT) of only 75 minutes, thereby making them convenient and reliable for use in screening for HBV infection.

Sources:
*https://www.pharmaceutical-technology.com/comment/world-hepatitis-day-2019/
**https://vilabin.com/article/hepatitis-b-causes-symptoms-types-prevention-and-vaccination/

Authored by:

Rashmi Jha
Asst. Product Manager- Immunology
Transasia Bio-Medicals Ltd.


Comments

Post a Comment

Popular posts from this blog

HbA1c: An Important Biomarker in diagnosis and prognosis of diabetes patients

-
Image
  One of the main purposes of laboratory tests is to aid medical reasoning after obtaining the clinical history and performing the physical examination by the laboratory team. To this end, all test execution phases, especially the pre-analytical phase, must be conducted following the technical rigor necessary to ensure patient safety and accurate results, so that the conduction of the patient's prognosis is more assertive. The measurement of HbA1c, when measured in whole blood, by immunoturbidimetric assay, in biochemical equipment from the XL family, such as the XL 200 equipment, plays an important role in the diagnosis of Diabetes. Diabetes is a global endemic with rapidly increasing prevalence in both developing and developed countries. The American Diabetes Association has recommended glycated hemoglobin (HbA1c) as a possible substitute to fasting blood glucose for diagnosis of diabetes. HbA1c is an important indicator of long-term glycemic control with the ability to refle
Read more

Overcome electrolytic analysis challenges with maintenance-free biosensor technology

-
Image
  Find out how to increase the accuracy and reduce the processing time of your routine electrolyte Electrolyte analyzers are routinely used in medical diagnostics to examine physiological conditions within the body. Hospitals and clinical laboratories, as well as treatment sites, rely on electrolyte analyzers to measure the concentration of different ions in the blood, providing important information about the body's electrolyte balance that can be used to detect metabolic imbalances, assess kidney and heart disease and contribute to the early detection of human diseases. However, despite their widespread use, electrolyte analyzers operating with traditional electrode technology are subject to a multitude of challenges, with the need for periodic replacement of electrodes, in particular. In this interview, we speak with Sourav Saha, Product Manager – Critical Care, to learn more about the issues facing clinical labs performing electrolyte analysis and how Erba EC 90, state-of-the
Read more

Biochemical liver markers

-
Image
  Liver function tests (also known as a liver panel) are blood tests that measure different enzymes, proteins, and other substances made by the liver. These tests check the overall health of your liver. Transasia offers a wide menu of test parameters in convenient pack sizes in powder and liquid stable formats as well as system packs for Erba range of fully automated analyzers. The use of serum biochemical tests plays an important role in the diagnosis and treatment of liver diseases. However, an isolated test provides limited information, which must be evaluated in the context of the patient's history and clinical condition. Biochemical liver tests consist of markers of hepatocellular injury (aminotransferases and alkaline phosphatase), liver metabolism tests (bilirubins), and liver synthetic function tests (serum albumin and prothrombin time [PT]).   Hepatic injury markers The liver contains a high concentration of enzymes, some of which are present in serum in very low concentra
Read more